---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-008562"
form_type: "8-K"
ticker: "DH"
cik: "0001861795"
company_name: "Definitive Healthcare Corp."
filed_at: "2024-01-16T23:59:59+00:00"
generated_at: "2026-06-06T23:28:53.636175+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# DH CEO Musslewhite steps down; Founder Krantz interim CEO; reaffirms Q4 guidance, issues 2024 preview

## Summary
- CEO Robert Musslewhite resigned effective Jan 16, 2024; departure is without cause; receives 15 months accelerated vesting and up to $15K in legal fees.
- Founder and Executive Chairman Jason Krantz appointed interim CEO, effective Jan 16, 2024; Board engaged search firm for permanent CEO.
- Company reaffirms Q4 2023 guidance provided on Nov 3, 2023; preliminary 2024 guidance: revenue growth 5-7% YoY, Adj. EBITDA margin +~200 bps.
- Krantz previously served as CEO from 2011 to Aug 2022, scaling the company to >$200M revenue and IPO in Sept 2021.

## SEC filing metadata
- accession: 0001193125-24-008562
- form_type: 8-K
- ticker: DH
- cik: 0001861795
- company_name: Definitive Healthcare Corp.
- filed_at: 2024-01-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/d683059d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-008562
- JSON: https://secwatch.observer/filing/0001193125-24-008562.json
- Plain text: https://secwatch.observer/filing/0001193125-24-008562.txt

## Key facts
- Earnings Releases
  Definitive Healthcare Corp. updated its the quarter ended December 31, 2023 guidance (reaffirmed).
  - Period: the quarter ended December 31, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On January 16, 2024, Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) issued a press release announcing the management changes described in Item 5.02 below and its reaffirmation of previously announced guidance for the quarter ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm
- Executive change
  Jason Krantz was appointed as Interim Chief Executive Officer at Definitive Healthcare Corp..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: On January 12, 2024, the Company’s Board of Directors appointed Jason Krantz, the Company’s founder and Executive Chairman, as Interim Chief Executive Officer, effective January 16, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm
- Executive change
  Robert Musslewhite departed as Chief Executive Officer at Definitive Healthcare Corp..
  - Action: stepped down
  - Role: Chief Executive Officer
  source text: On January 16, 2024, the Company announced that Robert Musslewhite has stepped down as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors, effective January 16, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861795/000119312524008562/0001193125-24-008562-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.